SOURCE: Bilcare

December 18, 2007 18:45 ET

Dr. APJ Abdul Kalam, Former President of India, Inaugurates Bilcare Centre of Excellence

Bilcare's Research Product Makes Counterfeit Drug Virtually Impossible

PUNE, INDIA--(Marketwire - December 18, 2007) - Former President of India, Dr. APJ Abdul Kalam and Dr. John L. LaMattina (Senior Vice President, Pfizer Inc and President, Pfizer Global Research & Development) inaugurated the Bilcare Centre of Excellence. The Centre will have dedicated R&D sections for Packaging Research, Material Research, Analytical Research, Drug Sensitivity Studies and Package Design. For converting the innovations into reality, the centre is also equipped with Asia's first integrated Flexo Printing machine and a state-of-the art pilot plant which was inaugurated by Dr. R Chidambaram, Principal Scientific Advisor to the Government of India.

According to the World Health Organization (WHO) 10% of global medicines, worth $50Bn are counterfeit and $150Bn revenue is lost due to compliance related issues. To combat this global crisis, Bilcare Research has developed a unique product which was also jointly launched by Dr. APJ Abdul Kalam & Dr. John L. LaMattina. This product will help the pharmaceutical industry in securing their brands, increasing every product's warranty, traceability and secure the supply chain management apart from eradicating counterfeit and ensuring better healthcare compliance.

Speaking on the occasion, Mr. Mohan Bhandari, Chairman & Managing Director, Bilcare Limited, said, "Bilcare is emerging fast as a knowledge company with unique research capabilities to address the critical challenges of the pharmaceutical industry. With this product and the R&D center launch, we are now in a position to offer complete solutions to our global customers on counterfeiting and ensure better healthcare for tomorrow."

Out of the major investments in nanotechnology research & development happening today, this is one of the first cost-effective and useful solutions for the common man offered by Bilcare.

About Bilcare:

Headquartered in India, Bilcare provides integrated packaging solutions across the entire spectrum of pharmaceutical value chain through five focused business activities -- Research Services, Clinical Supplies, Design Lab, Research Academy and Packaging Materials. Bilcare operates state-of-the art manufacturing facilities in India, Singapore, US & UK and has regional offices in Brazil, Germany, China & Australia which caters to global clients, including J&J, Merck, GSK, Sanofi, Pfizer, Novartis, Wyeth, Ranbaxy, Dr. Reddy to name a few. Bilcare Research is increasingly changing the face of pharma industry by enabling global pharmaceuticals companies and their brands with better communication, patient compliance, cost, convenience and checking counterfeit through its innovative solutions.

Contact Information

  • Contact:
    Jaydip Chowdhury
    Email Contact
    Head Corporate Communications
    Bilcare Research